News

FDA Approves Auvelity: A New Option for MDD

FDA · Major Depressive Disorder (MDD) · 5 min

Sun Pharma Organon Partnership to Expand Access to Key Medicines

women's health, spasticity, rheumatoid arthritis · 6 min

UCB Acquires Candid Therapeutics for $2.2 Billion, Expanding T-Cell Engager Platform for Autoimmune Diseases

Autoimmune and inflammatory diseases · 3 min

FDA Approves Auvelity for MDD: A New Antidepressant Option

FDA · Major Depressive Disorder · 6 min

a2 Milk Company Recalls Three Batches of a2 Platinum Infant Formula Due to Health Risk Concerns

Infant Nutrition · 3 min

FDA Approves Auvelity for MDD: Axsome Therapeutics' New Antidepressant

FDA · Major Depressive Disorder · 6 min

Vector Science & Therapeutics Files Patent for Microneedle Catheter Platform for Cancer Drug Delivery

2 min

Apotex Receives First Canadian Health Canada Approval for Generic Ozempic (Semaglutide) Alternative

2 min

Keenova Therapeutics Presents New TERLIVAZ Clinical Data for Hepatorenal Syndrome at Digestive Disease Week 2026

2 min

Kodiak Sciences KSI-101 Clinical Data to Be Presented at Scientific Conferences for Macular Edema Treatment

2 min

NAMSA and Lexitas Form Strategic Partnership for Comprehensive Ophthalmic Medical Device Development Services

2 min

Verified Clinical Trials Partners with Chubb to Enhance Patient Safety and Data Quality in Clinical Research

2 min